Rakuten Medical

📍 San Diego, United States🗓 Founded 2010👥 134 employees💰 Last funded Jul 2021
Biotechnology🌐 rakuten-med.com
Website LinkedIn
Rakuten Medical, Inc. is a global biotechnology company developing and commercializing precision, cell-targeting investigational therapies on its AlluminoxTM platform, which, in pre-clinical studies have been shown to induce rapid and selective cell killing and tumor necrosis. Outside of Japan, Alluminox therapies have not yet been approved as safe or effective by any regulatory authority. The company’s first drug developed on the Alluminox platform, ASP-1929, has received approval from the Japanese Ministry of Health, Labour, and Welfare, and is currently the subject of a global phase 3 clinical trial for recurrent head and neck cancer. Rakuten Medical is committed to its mission to conquer cancer by delivering our innovative treatments as quickly and safely as possible to as many patients all over the world as possible. The company has locations in 6 countries, including the United States, where it is headquartered, Japan, Taiwan, the Netherlands, Switzerland and India. For more information, visit www.rakuten-med.com.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2010
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Rakuten Medical?
Rakuten Medical has 1 investors on record on gritt.io.
When did Rakuten Medical last raise funding?
The most recent investment in Rakuten Medical recorded on gritt.io was in July 2021.
When was Rakuten Medical founded?
Rakuten Medical was founded in 2010.
What industry is Rakuten Medical in?
Rakuten Medical operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Rakuten Medical based?
Rakuten Medical is headquartered in San Diego, United States.